Paraffin sections of 11 formalin-fixed trichilemthe genital HPVs (A); the epidermodysplasia verrucimomas were investigated for the presence of formis (EV)-associated HPVs (B); ungulate associated human papillomavirus (HPV) DNA by the polypapillomaviruses (C and D) and cutaneous HPVs (E) merase chain
Detection of HPV DNA in archival specimens of cervical cancer using in situ hybridisation and the polymerase chain reaction
β Scribed by Carol H. Thompson; Barbara R. Rose; Yvonne E. Cossart
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 860 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
An archival survey of 98 cervical cancer specimens dating from the 1920s to the 1980s was undertaken to determine whether changes had occurred in the prevalence of human papillomavirus (HPV) DNA. HPV DNA was detected in paraffin sections of cancers fixed in 10% formalin by in situ hybridisation (ISH) using HPV 6, 11, 16, and 18 32Pβlabelled DNA probes under conditions of high stringency; and by the polymerase chain reaction (PCR) using 20βmer oligonucleotide primers to amplify 109 bases of the E6 region of HPV 16. In 30 instances results obtained from Southern blot hybridisations which had been carried out on specimens of fresh tissue from the same cancers collected during the 1980s were available for comparison. The rates of HPV DNA detection in cervical cancers ranged from 83% (by Southern or PCR) and 70% (by ISH) on specimens from the 1980s, to 50% and 63% (by ISH and PCR, respectively) on specimens from the 1920s. HPV 16 was by far the most common type, being identified by Southern or ISH i n approximately 92% of HPV DNAβ positive specimens. No significant change in the prevalence of HPV DNA, or of HPV types, in cervical cancers was found over the 65 year period examined.
π SIMILAR VOLUMES
## Abstract A gene amplification method that combines the polymerase chain reaction with detection of amplified DNA in a solution hybridization/enzyme immunoassay (PCRβEIA) was developed for HPVβ16 DNA. Samples were amplified with primers for the E7βE1 region of HPVβ16. Amplified DNA products were
## Abstract The overall prevalence of human papillomavirus (HPV) cervical infection in 131 women attending a family planning clinic was 7% (HPV 6/11,16,18,31) by dot blot hybridisation, 53% (HPV 11,16,31) by polymerase chain reaction (PCR), and 56% by the two methods combined. HPV 16 and 18 were th
Persistent infection of the uterine cervix with high-risk human papillomaviruses (HPV) is causally associated with cancer of the cervix. A few studies have reported the presence of HPV DNA in the blood of women with cervical neoplasia. The aim of this study was to determine if HPV DNA could be detec
## Abstract The polymerase chain reaction (PCR) was applied for the detection of human papilloma virus (HPV) infection, in samples obtained from the uterine cervices of 202 asymptomatic women with normal cytology in Northern Greece. About 41.8% of the women with microscopically and cytologically no
In order to determine the prevalence and type-specific distribution of human papillomavirus (HPV) in women from Pakistan, a country with a low cervical cancer rate (hospitalbased data), and to compare these results with their counterparts in Japan, we studied 56 non-neoplastic cervical tissues and 1